What changed
$DG — WATCHLIST 📊 | 6 MONTHS THESIS
🧭 Conviction: MED
🎯 FQ1 FY2027 (ends Apr) | reported Jun 02 | Rev $10.8B | EPS $2.00 vs $1.89 🟢 | Margin 5.9%
💡 Consensus expects continued margin pressure and weak same-store sales. The 5.8% EPS beat may signal early resilience, but one quarter is insufficient to confirm a trend; the market likely needs multiple beats to re-rate.
🏢 Business Quality: 4/10
📊 Valuation: fair — trailing P/E 14.9x is below sector median (~18-20x) and DG's 5-year average (~18x), but justified by lower margins and growth concerns; FCF...
🔮 Catalyst: Q2 FY2027 earnings release
⚖️ Watchlist: Recent EPS beat is encouraging but insufficient to overcome deeply negative quant rankings and mediocre FCF yield; wait for sustained margin improvement before committing capital.